Navigation Links
Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting
Date:12/6/2007

beginning on Monday.

About the Phase 3 Clinical Trial of Specifid

Favrille initiated a pivotal, double-blind, placebo controlled Phase 3 clinical trial of Specifid in patients with follicular B-cell NHL in July 2004. Patient registration was completed in January 2006 and the last of the 349 patients was randomized in June 2006. Approximately 80 percent of the patients randomized in the trial were treatment naive, with the remainder either relapsed from or refractory to prior therapy. The Company anticipates analysis of the primary endpoint for the trial, time to disease progression (TTP), no later than July 2008. The pivotal Phase 3 trial is being conducted under a Special Protocol Assessment from the U.S. Food and Drug Administration (FDA). Favrille has also received Fast Track designation from the FDA for Specifid.

About Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, Specifid (formerly FavId), is based upon unique genetic information extracted from a patient's tumor. Specifid is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Favrille's product candidates, proprietary technologies and research programs. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may
'/>"/>

SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Virginia Tech Report Has National Importance
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
4. Haemacure Reports Third Quarter 2007 Results
5. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
6. Biotech Finishes on a High in August, Burrill Report Says
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. First New York/New Jersey Health Care Report Card Released
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... La Mirada, CA (PRWEB) April 27, 2015 ... various minimally invasive treatments for nail fungi and infections. ... believed to affect up to 10% of adults in ... discoloration, fragility, and irregularity in thickness. , ... Laser Institute , a branch dedicated to providing quality ...
(Date:4/27/2015)... Texas has saved $433 million by converting ... providing drug offenders with addiction treatment, according to an ... Several states, including Massachusetts, are considering adopting justice reinvestment ... formed community recovery programs to help redress rampant addiction ... State Governments WA, ID, NE, KS, MI, PA, ...
(Date:4/27/2015)... Consumer Choice Award is thrilled to announce the ... Ottawa. We would like to extend heartfelt congratulations to ... has resonated with the people of Ottawa. , Each ... and expectations through the responses of thousands of consumers ... selection process conducted by a third party research firm ...
(Date:4/27/2015)... The Sanford J. Grossman Charitable Trust, founded ... has committed $3 million to establish the Dr. Sanford ... Disease at the Icahn School of Medicine at Mount ... for treatment of Crohn’s disease, with the overarching goal ... a chronic inflammatory disorder of the bowel first described ...
(Date:4/27/2015)... CA (PRWEB) April 27, 2015 Final ... top of footage with ProTelestrator from Pixel Film Studios. A ... a freehand sketch over a moving or still video image. ... diagram and analyze sports plays or incoming weather patterns. , ... checkbox and then adjust the frame slider to control the ...
Breaking Medicine News(10 mins):Health News:Southern California Healthpointe Clinics Now Treating Nail Fungus 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:2015 Ottawa Consumer Choice Award-Winners 2Health News:2015 Ottawa Consumer Choice Award-Winners 3Health News:2015 Ottawa Consumer Choice Award-Winners 4Health News:2015 Ottawa Consumer Choice Award-Winners 5Health News:2015 Ottawa Consumer Choice Award-Winners 6Health News:2015 Ottawa Consumer Choice Award-Winners 7Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 2Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 3Health News:Pixel Film Studios releases ProTelestrator for Final Cut Pro X. 2
... Rock and Roll Hall of Famer, Marky Ramone of the world-famous ... ... NEW YORK, Feb. 7 The American Social Health Association,(ASHA) recognizes ... sex practices have never been more critical. Despite,hundreds of millions of ...
... 19, 9 a.m. - 5 p.m.), SCOTTSDALE, Ariz., ... Dental Health Month. Dr. Lee Weinstein, a leading ... Associates for Kids Only, will be offering a Free Children,s ... until 5 p.m., The first 30 patients that call ...
... zebrafish in a bid to understand the causes of an ... team will use the model organism to investigate Lowe syndrome, ... a rare disorder that produces cataracts of the eyes, defects ... said Dr Martin Lowe, who will head the research. , ...
... react to stress may provide an important clue to ... reduce their painful effects, says Queens University Biology professor ... Robertson is using insect models to examine how the ... high temperatures and oxygen deprivation. They have discovered that ...
... Operations Research and the Management Sciences (INFORMS) today announced ... Edelman Award for Achievement in Operations Research and the ... , Reflecting the wide-ranging use of operations ... teams from Western Europe, and two federal agencies. , ...
... for Military Biomaterials Research (CeMBR), part of the New ... the development of a breakthrough spray-on dressing for injuries. ... medical device company in Norcross, Ga., received clearance for ... Feb. 1. , The GelSpray Liquid Bandage is a ...
Cached Medicine News:Health News:Beating to the Drum of Safe Sex 2Health News:Beating to the Drum of Safe Sex 3Health News:Free Children's Dental Day; Expert Source on Children's Dental Health Available 2Health News:Might fish provide Lowe-down on boyhood disease? 2Health News:Comatose locusts may help relieve migraines 2Health News:World's best analysts compete to win Edelman Prize in operations research and analytics 2Health News:Rutgers center sparks 'liquid bandage,' a new frontline wound treatment 2
(Date:4/25/2015)... 25. April 2015 Hospira, Inc. ... der Entwicklung von Biosimilar-Behandlungen, sprach heute auf der ... Generikaverbands (EGA) in London ... der Verfügbarkeit von Biosimilars für Patienten. ... White Papers mit dem Titel „Why extrapolation ...
(Date:4/24/2015)... 24, 2015  Perrigo Company plc ("Perrigo" or the ... the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: ... of Perrigo for $60.00 per share in cash and ... (the "Offer").  The Board previously concluded ... undervalued the Company and its future growth prospects and ...
(Date:4/24/2015)... N.C. , April 24, 2015  New ... ability of consumers to educate themselves about products ... the tools and techniques available to market researchers ... the changing consumer marketplace, it,s imperative that organizations ... to better identify market opportunities, niches and growth ...
Breaking Medicine Technology:Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 2Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 3Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 4Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 5Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 6Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 7Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 8Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2
... April 18, 2012  CAQH® announced today that ... the Universal Provider Datasource® (UPD®), demonstrating that ... standard for self-reported provider data used to ... network directories, referrals and claims administration. ...
... Live has revealed further details of the newest event ... (SEA) 2012. Set to debut from 10-12 May 2012 at ... first trade show and exhibition of its kind to be ... CPhI SEA will provide a meeting place ...
Cached Medicine Technology:One Million Healthcare Providers Now Use the CAQH Universal Provider Datasource 2One Million Healthcare Providers Now Use the CAQH Universal Provider Datasource 3Leading Pharma Ingredients Event Debuts in Growing ASEAN Market 2Leading Pharma Ingredients Event Debuts in Growing ASEAN Market 3
Latex-free coronary artery perfusion/cardioplegia infusion cannulae....
... OXYPLETH is seven pounds of intelligent ... combined with software developed over 7 ... provides the ultimate in non-invasive oxygen ... oximeter monitor technology and sophisticated saturation ...
... Oximeter is a lightweight, portable console display module. ... two separate channels for up to one or ... as adjustable alarms for low and high limits ... user friendly and requires minimal training., ,Sensors of ...
... the Novametrix' family of capnography products. Along ... are the only handheld, mainstream capnographs available ... patient's airway condition and ventilatory status. Based ... capnographs, we miniaturized the size, not the ...
Medicine Products: